Stock CRRTF CRESCITA THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Crescita Therapeutics Inc. OTC Markets

Equities

CRRTF

CA2258471028

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 02:14:05 2024-04-02 pm EDT 		5-day change 1st Jan Change
0.32 USD -0.16% Intraday chart for Crescita Therapeutics Inc. 0.00% +14.29%
Mar. 13 Crescita Therapeutics Reports Q4 Net Loss of $0.01 Per Share MT
Mar. 13 Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023. CI

Business Summary

Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and sales of product development services.

Sales per Business

CAD in Million2022Weight2023Weight Delta
Commercial Skincare
59.6 %
8 34.1 % 10 59.6 % +30.14%
Manufacturing and Services
28.8 %
14 58.2 % 5 28.8 % -63.13%
Licensing and Royalties
11.6 %
2 7.7 % 2 11.6 % +12.78%

Sales per region

CAD in Million2022Weight2023Weight Delta
Canada
66.9 %
10 41.6 % 12 66.9 % +19.74%
United States
23.8 %
12 51.6 % 4 23.8 % -65.58%
Rest-of-World
9.2 %
2 6.8 % 2 9.2 % +1.38%

Managers

Managers TitleAgeSince
Serge Verreault CEO
 Chief Executive Officer - -
Jose DaRocha DFI
 Director of Finance/CFO - 17-08-31
Daniel Chicoine CHM
 Chairman 70 16-02-29
Wade Hull CTO
 Chief Tech/Sci/R&D Officer - 16-02-29
Linda Kisa IRC
 Investor Relations Contact - -
Ramirez Medina PRN
 Corporate Officer/Principal - 21-05-31
Isabelle Villeneuve PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Anthony Dobranowski BRD
 Director/Board Member - 16-02-29
Daniel Chicoine CHM
 Chairman 70 16-02-29
John London BRD
 Director/Board Member - 16-02-29
Deborah Trudeau BRD
 Director/Board Member - 21-11-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,541,391 17,519,341 ( 89.65 %) 0 89.65 %

Shareholders

NameEquities%Valuation
Daniel Chicoine
5.290 %
1,057,377 5.290 % 311 926 $
Serge Verreault
3.711 %
741,751 3.711 % 218 817 $
Jose DaRocha
1.251 %
250,001 1.251 % 73 750 $
John London
0.9681 %
193,522 0.9681 % 57 089 $
Attitude Gestión SGIIC SA
0.8155 %
163,007 0.8155 % 48 087 $
Anthony Dobranowski
0.5003 %
100,000 0.5003 % 29 500 $
Wade Hull
0.1970 %
39,384 0.1970 % 11 618 $
Francois Lafortune
0.000000 %
0 0.000000 % - $
Isabelle Villeneuve
0.000000 %
0 0.000000 % - $
Ramirez Medina
0.000000 %
0 0.000000 % - $

Company contact information

Crescita Therapeutics, Inc.

2805 Place Louis-R Renaud

H7V 0A3, Laval

+

http://www.crescitatherapeutics.com
address Crescita Therapeutics Inc.(CRRTF)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CTX Stock
  4. CRRTF Stock
  5. Company Crescita Therapeutics Inc.